This bill aims to formally repeal the Prescription Drug Affordability Board, which has already been effectively dissolved by previous legislation (HB 2 from the 2025 session). The bill includes specific amendments to existing law, such as deleting the position of the executive director of the Prescription Drug Affordability Board from the salary schedule in RSA 94:1-a, I(b). Additionally, it repeals provisions related to the New Hampshire Prescription Drug Affordability Board, including the administration fund outlined in RSA 6:12, I(b)(384) and the entirety of RSA 126-BB.

The effective date for this repeal is set for July 1, 2025. The fiscal note accompanying the bill indicates that there will be no financial impact, as the Board's functions and funding have already been eliminated, resulting in no expected revenue or expenditures related to this repeal.

Statutes affected:
Introduced: 126-BB:1, 126-BB:2